assessment of cytokine
induction, cells were brought up to 1.25 × 106 cells/mL
and seeded in 96-well U-bottomed plates with 200 μL per well.
RNA/DNA fibers at 1 μM stock solution were complexed to Lipofectamine
2000 (L2K) at a 5:1 v/v ratio. After a 30 min incubation at room temperature,
OptiMEM was added, bringing the final concentration of fibers to 50
nM. Afterward, 40 μL of the prepared controls and NANPs were
added to PBMC for a final stimulation concentration of 10 nM. As the
positive controls, LPS (final 20 ng/mL, Invitrogen), ODN2216 (final
5 μg/mL), and PHA-M (final 10 μg/mL, Sigma) were added
to PBMCs. As a negative control, blank media was added to PBMCs. All
treatments were added to wells in technical duplicates for each donor.
After 20 h of incubation at 37 °C, the plate was spun down at
700g for 10 min. 170 μL of supernatant was
collected from each well and transferred into a new 96-well plate
for analysis of cytokines by multiplexed ELISA (Q-Plex Mouse Cytokine
– Inflammation (14-plex) and Q-Plex Human Cytokine –
HS Screen (15-plex) from Quansys Biosciences) according to the manufacturer’s
instructions. Supernatants from the three positive controls were pooled
1:1:1. Plates were imaged on a Quansys Biosciences Q-View Imager Pro.63 (link)